Table 2.
Characteristics | Patients without cancer (n = 106) | Patients with cancer (n = 94) | P-value |
---|---|---|---|
Mean age (y) [range] | 70 (52–87) | 71 (48–88) | 0.675 |
total PSA (ng/ml) | 11.079 ± 9.013 | 57.002 ± 125.88 | <0.001 |
Position, no. | |||
Peripheral zone | 44 | 63 | <0.001 |
Transitional zone | 62 | 31 | |
Gleason score (n, %) | |||
6 | —— | 8 | |
7 | —— | 46 | |
8 | —— | 24 | |
9 | —— | 16 |
The data are mean ± standard deviation, unless otherwise indicated.
PSA, prostate-specific antigen.